Impel NeuroPharma

Impel NeuroPharma

Impel NeuroPharma

Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier.
Type
B2c
Founded
2008
Raised
$187.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$80,000,000
IPO - 2021
$67,500,000
Venture capital - 2018
Team Size
10+
Employees
GeekWire , MedCity News

Impel NeuroPharma, fresh off IPO, gets FDA approval for nasal spray that treats migraines

$80,000,000 IPO
GeekWire

Impel Neuropharma raises $80M in Washington state’s first IPO of 2021

GeekWire

Seattle biotech firm Impel NeuroPharma files for $75M IPO

FinSMEs

Impel NeuroPharma Closes $67.5M in Series D Financing

$67,500,000 Venture capital
GeekWire , PE HUB

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity

$36,000,000 Venture capital (Series C)
GeekWire , FinSMEs

Impel NeuroPharma raises $36M for drug delivery platform that bypasses blood-brain barrier

Health